Jul 10, 2026 · 1 hr 11 min · 12 segments
In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca…
Eduardo FonsecaGuest
Tom SalemiHost
Chris NewmarkerHost
XCAF made some news late last year when it announced that it's ISIS system had been used in the first telesurgery stroke treatment, and we'll talk a bit about that with Eduardo in the conversation.
I mean, clearly, stroke is an area, I think, where surgical robotics can do a great deal of good, can provide care for millions who aren't able to receive it right now, who are just not close enough to the talented neurologists and neurosurgeons and interventionists who perform these procedures.
And we're going to unpack what they're doing, not only here on the podcast, but a little later this month.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
XCAF made some news late last year when it announced that it's ISIS system had been used in the first telesurgery stroke treatment, and we'll talk a bit about that with Eduardo in the conversation.
I mean, clearly, stroke is an area, I think, where surgical robotics can do a great deal of good, can provide care for millions who aren't able to receive it right now, who are just not close enough to the talented neurologists and neurosurgeons and interventionists who perform these procedures.
And we're going to unpack what they're doing, not only here on the podcast, but a little later this month.